Teladoc Health, Inc.
TDOC
$6.36
-$0.25-3.78%
NYSE
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -4.43% | 2.53% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -4.43% | 2.53% | |||
| Cost of Revenue | 0.24% | 5.27% | |||
| Gross Profit | -6.49% | 1.36% | |||
| SG&A Expenses | -0.28% | -4.09% | |||
| Depreciation & Amortization | -2.69% | 7.32% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.00% | 1.11% | |||
| Operating Income | -80.69% | 23.94% | |||
| Income Before Tax | -80.98% | 33.06% | |||
| Income Tax Expenses | 135.34% | -1,085.31% | |||
| Earnings from Continuing Operations | -153.90% | 49.21% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -153.90% | 49.21% | |||
| EBIT | -80.69% | 23.94% | |||
| EBITDA | -80.88% | 168.50% | |||
| EPS Basic | -152.05% | 49.46% | |||
| Normalized Basic EPS | -93.06% | 27.46% | |||
| EPS Diluted | -152.05% | 49.46% | |||
| Normalized Diluted EPS | -93.06% | 27.46% | |||
| Average Basic Shares Outstanding | 0.73% | 0.51% | |||
| Average Diluted Shares Outstanding | 0.73% | 0.51% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||